Literature DB >> 1195779

C-peptide analysis in diagnosis of factitial hypoglycemia in an insulin-dependent diabetic.

F J Service, A Rubenstein, D L Horwitz.   

Abstract

Factitial hypoglycemia from the surreptitious self-administration of insulin by an insulin-dependent diabetic, shown to have C-peptide secretory ability by glucose and tolbutamide stimulation tests, was strongly suspected by finding low plasma C-peptide immuno-reactivity and high plasma insulin levels during "spontaneous" hypoglycemia whereas during hyperglycemia the D-peptide immunoreacitivity was higher and the plasma insulin was lower.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 1195779

Source DB:  PubMed          Journal:  Mayo Clin Proc        ISSN: 0025-6196            Impact factor:   7.616


  6 in total

Review 1.  Factitious disorders presenting as acute emergencies.

Authors:  A Banerjee
Journal:  Postgrad Med J       Date:  1994-02       Impact factor: 2.401

Review 2.  The expanding clinical use of C-peptide radioimmunoassay.

Authors:  M Rendell
Journal:  Acta Diabetol Lat       Date:  1983 Apr-Jun

3.  [Studies on the question of a possible autoregulation of insulin secretion (author's transl)].

Authors:  T Zilker; K Paterek; R Ermler; P Bottermann
Journal:  Klin Wochenschr       Date:  1977-05-15

4.  [The C-peptide suppression test in normal persons and insulinoma patients: an attempt to evaluate its use in functional diagnosis (author's transl)].

Authors:  H Mandelkow; K Goetz; J Kühnau
Journal:  Klin Wochenschr       Date:  1981-11-02

5.  The validity of C-peptide measurement in the diagnosis of factitious hypoglycemia.

Authors:  G Dimitriadis; S Raptis; C Zoupas; N Schizas
Journal:  Acta Diabetol Lat       Date:  1980 Jan-Mar

Review 6.  Determination of insulin for the diagnosis of hyperinsulinemic hypoglycemia.

Authors:  Diva D De León; Charles A Stanley
Journal:  Best Pract Res Clin Endocrinol Metab       Date:  2013-07-09       Impact factor: 4.690

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.